GoodRx Holdings (GDRX) Tax Provisions (2019 - 2026)

GoodRx Holdings has disclosed Tax Provisions across 8 years of filings, most recently posting $4.5 million for Q1 2026.

• Tax Provisions for Q1 2026 came in at $4.5 million, down 20.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.0 million (up 28.73% YoY), and the FY2025 annual result was $26.1 million, up 73.19% from the prior year.
• Tax Provisions came in at $4.5 million for Q1 2026 at GoodRx Holdings, down from $8.8 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $19.5 million in Q3 2022 to a low of -$46.7 million in Q2 2023.
• The 5-year median for Tax Provisions is $4.5 million (2026), against an average of $501882.4.
• Across the five-year window, Tax Provisions sank 434.29% in 2023 and soared 331.34% in 2025, its largest moves.
• GoodRx Holdings' Tax Provisions stood at -$2.8 million in 2022, then soared by 144.5% to $1.2 million in 2023, then jumped by 278.36% to $4.7 million in 2024, then soared by 87.79% to $8.8 million in 2025, then plunged by 49.02% to $4.5 million in 2026.
• The last three Tax Provisions figures came in at $4.5 million (Q1 2026), $8.8 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.